LPL Financial’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Buy |
25,901
+908
| +4% | +$15.8K | ﹤0.01% | 4384 |
|
|
2025
Q1 | $314K | Buy |
24,993
+3,585
| +17% | +$45.1K | ﹤0.01% | 4444 |
|
|
2024
Q4 | $226K | Buy |
21,408
+2,190
| +11% | +$23.1K | ﹤0.01% | 4631 |
|
|
2024
Q3 | $279K | Buy |
19,218
+9,039
| +89% | +$131K | ﹤0.01% | 4403 |
|
|
2024
Q2 | $86.6K | Buy |
+10,179
| New | +$86.6K | ﹤0.01% | 4665 |
|